BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,124 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $820,429 | -73.8% | 19,277 | -63.9% | 1.09% | +54.7% |
| Q2 2022 | $3,128,000 | +55.5% | 53,467 | +102.5% | 0.70% | +52.7% |
| Q1 2022 | $2,011,000 | -33.7% | 26,409 | -30.0% | 0.46% | -27.4% |
| Q2 2021 | $3,032,000 | +90.0% | 37,731 | +88.0% | 0.64% | +4.3% |
| Q3 2020 | $1,596,000 | +2.4% | 20,068 | +8.4% | 0.61% | +55.8% |
| Q2 2020 | $1,558,000 | +272.7% | 18,516 | +263.1% | 0.39% | +234.2% |
| Q1 2020 | $418,000 | -71.1% | 5,100 | -68.7% | 0.12% | -75.6% |
| Q3 2019 | $1,447,000 | +348.0% | 16,300 | +317.9% | 0.48% | +163.2% |
| Q2 2019 | $323,000 | -8.0% | 3,900 | -24.5% | 0.18% | -23.2% |
| Q3 2018 | $351,000 | +62.5% | 5,168 | +59.7% | 0.24% | +119.4% |
| Q1 2018 | $216,000 | -82.8% | 3,236 | -81.9% | 0.11% | -84.0% |
| Q4 2017 | $1,256,000 | +9.3% | 17,900 | +0.9% | 0.67% | +5.2% |
| Q3 2017 | $1,149,000 | +325.6% | 17,735 | +297.8% | 0.64% | +326.7% |
| Q2 2017 | $270,000 | -36.8% | 4,458 | -57.1% | 0.15% | -55.5% |
| Q1 2016 | $427,000 | – | 10,400 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |